Hybrid compounds as new Bcr/Abl inhibitors.
Wang D, Zhang Z, Lu X, Feng Y, Luo K, Gan J, Yingxue L, Wan J, Li X, Zhang F, Tu Z, Cai Q, Ren X, Ding K.
Wang D, et al. Among authors: lu x.
Bioorg Med Chem Lett. 2011 Apr 1;21(7):1965-8. doi: 10.1016/j.bmcl.2011.02.029. Epub 2011 Feb 13.
Bioorg Med Chem Lett. 2011.
PMID: 21376587